Elena Ridloff

Elena is Chief Financial Officer & Head of Corporate Development of Sionna. She has over 20 years of experience in finance and the life sciences industry. Most recently she served as Executive Vice President and Chief Financial Officer for Acadia Pharmaceuticals where she was responsible for leading the corporate finance, accounting, investor relations, corporate affairs and government affairs functions. During her tenure at Acadia, Elena played a critical role in the organization’s commercial, business development and pipeline growth including successfully raising $600 million in capital.

Prior to Acadia, Elena was Vice President, Investor Relations at Alexion Pharmaceuticals and served as a member of the Operating Committee. Additionally, Elena was Chief Executive Officer of BIOVISIO, an independent consulting firm serving the life sciences industry. She was also a Managing Director at Maverick Capital, a hedge fund, and was responsible for investments in the biotechnology, pharmaceutical and life science sectors. She currently serves on the Board of Directors of Kronos Bio, Inc. and Kymera Therapeutics, Inc. Elena received her B.A. in history and sociology of science from the University of Pennsylvania. She is also a CFA© charterholder.